Reviews and feature articlesThe role of the nervous system in rhinitis
Section snippets
Sensory nerves
The sensory nerves of the nose arise from the olfactory nerve, as well as from the ophthalmic (through the ethmoidal nerve) and maxillary branches of the trigeminal nerve.1, 2, 3 Nonolfactory sensory nerves consist of both myelinated and unmyelinated fibers. Unmyelinated fibers are slow conducting and, in the vast majority, belong to the nociceptor, C-fiber type. Myelinated fibers are of larger diameter and have faster nerve conduction velocity, and their function has not been fully elucidated.
Nasal symptoms and the nervous system
Fig 1 schematically depicts how nasal symptoms can be produced by neural mechanisms. Exogenous stimuli of various natures (physical or chemical), as well as endogenous biochemical products, can activate sensory nerve endings that are in abundance in the nasal mucosa, interdigitating between epithelial cells. Action potentials are transmitted to the cell bodies of the trigeminal ganglion and further into the midbrain, where secondary synapses eventually lead to the generation of central reflex
Neural hyperresponsiveness in allergic rhinitis
The fact that typical symptoms of rhinitis can be produced through neural mechanisms in the absence of any obvious abnormality in the nasal mucosa indicates that these symptoms are part of the normal function of the respiratory system. Teleologically, they provide primary defenses against external danger signals, whether physical or chemical. The question is why these symptoms are exaggerated in the case of allergic rhinitis. As discussed above, an obvious answer is that the products of
Does nonallergic rhinitis represent a state of neural hyperresponsiveness?
Nonallergic rhinitis consists of a variety of syndromes that are only to some extent distinguishable based on clinical and, in some cases, laboratory characteristics.126, 127 A large subgroup of patients with nonallergic rhinitis have nasal symptoms in the absence of any inflammatory changes in the nasal mucosa or any evidence of an infectious, systemic, or metabolic process. Several terms have been used to describe this group of patients, including nonallergic, noninfectious rhinitis;
Mechanisms of neural hyperresponsiveness in the nose
The mechanisms through which the nervous system can undergo changes that manifest with the hyperresponsiveness phenotype are steadily being unveiled, primarily in animal models.149, 150, 151, 152 Changes in neuronal function can occur at various levels, from sensory nerve endings to sensory ganglia, the central nervous system, autonomic ganglia, or the postganglionic-effector cell junctions. Most of these changes are associated with local inflammatory events, but the mechanisms might differ
The nerves of the nose as a conduit for systemic interactions
Every aspect of the function of the nose, from olfaction to air conditioning to airborne particle trapping, is associated with defensive and homeostatic mechanisms of the body. This widespread and demanding operation has to rely on an effective and fast communication system, through which danger signals can be transmitted to specific response centers. The systemic circulation can certainly play a part in this role; however, the reaction time and the specificity of circulatory signals do not
Conclusions
Chronic rhinitis in its various forms is an extremely common problem. Despite the availability of several forms of treatment, a substantial number of patients with rhinitis are not satisfied with the outcomes and seek additional medical care. To improve our therapeutic modalities, we need to further our understanding of the pathophysiology of rhinitis, both of allergic and nonallergic origin. A central approach toward this goal is to understand how symptoms are generated and what makes a
References (215)
Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa
J Allergy Clin Immunol
(1992)- et al.
Pharmacology of chronic pain
Trends Pharmacol Sci
(1994) - et al.
Characterization of cat nasal afferents and brain stem neurones receiving ethmoidal input
Exp Neurol
(1989) - et al.
Nasal sensory nerve populations responding to histamine and capsaicin
J Allergy Clin Immunol
(2005) - et al.
A beta-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent A-fiber neurons in mammals
Brain Res Brain Res Rev
(2004) - et al.
Central projections of trigeminal primary afferents innervating the nasal mucosa: a horseradish peroxidase study in the rat
Neuroscience
(1991) - et al.
C-Fos-like immunoreactivity in the cat brainstem evoked by sneeze-inducing air puff stimulation of the nasal mucosa
Brain Res
(1995) Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation
Neurosci Lett
(1981)- et al.
Capsaicin pretreatment inhibits the flare components of the cutaneous allergic reaction in man
Eur J Pharmacol
(1985) - et al.
Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients
J Allergy Clin Immunol
(1993)
Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation
J Allergy Clin Immunol
Molecular basis of muscarinic acetylcholine receptor function
Trends Pharmacol Sci
The physiology and pathophysiology of the parasympathetic nervous system in nasal disease: an overview
J Allergy Clin Immunol
How and why the nose runs
J Allergy Clin Immunol
Sympathetic control of nasal blood flow in the rat mediated by alpha(1)-adrenoceptors
Eur J Pharmacol
Trigeminal afferences implied in the triggering or inhibition of sneezing in cats
Neurosci Lett
Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes
J Allergy Clin Immunol
The effect of terfenadine on unilateral nasal challenge with allergen
J Allergy Clin Immunol
Blood and nerve supply of the nasal lining
Comparative anatomy of the nasal and tracheal/bronchial airways
The axon reflex: an outdated idea or a valid hypothesis?
NIPS Proc
Gastrin-releasing peptide in human nasal mucosa
J Clin Invest
Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
Br J Pharmacol Chemother
Role of tachykinins in neurogenic inflammation
J Immunol
Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea
Acta Physiol Scand
Capsaicin sensitive substance-P nerves: antidromic vasodilation and increased vascular permeability in the nasal mucosa
Br J Pharmacol
Increased vascular permeability In rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons
Acta Otolaryngol
Local and systemic capsaicin pretreatment inhibits sneezing and the increase in nasal vascular permeability induced by certain chemical irritants
Naunyn Schmiedebergs Arch Pharmacol
Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cells
J Neurocytol
Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability
J Neurocytol
Neuropeptides and nasal secretion
Am J Physiol
Neurogenic inflammation of the rat trachea: fate of neutrophils that adhere to venules
J Appl Physiol
NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea
Am J Physiol Lung Cell Mol Physiol
Neuro-immune interactions in the lung
Clin Exp Allergy
The role of substance P in inflammatory disease
J Cell Physiol
Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis
Allergy
Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons
Pharmacol Rev
Tachykinins and calcitonin gene-related peptide: co-existence in sensory nerves of the nasal mucosa and effects on blood flow
Cell Tissue Res
Calcitonin gene-related peptide in human nasal mucosa
Am J Physiol Lung Cell Mol Physiol
Substance P and neurokinin A in human nasal mucosa
Am J Respir Cell Mol Biol
Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal humans
Am J Respir Crit Care Med
Expression of substance P (NK1) receptor mRNA in human nose
Acta Otolaryngol
Expression of neurokinin A receptor mRNA in human nasal mucosa
Acta Otolaryngol
Inflammatory cellular influx follows capsaicin nasal challenge
Am J Respir Crit Care Med
Plasma extravasation through neuronal stimulation in human nasal mucosa
J Appl Physiol
Electron microscopy of the nasal vascular bed and its nerve supply
Ann Otol Rhinol Laryngol
Fine structure of the arteriovenous anastomosis and its nerve supply in the human nasal respiratory mucosa
Anat Rec
The cholinergic innervation of the human nasal mucosa
Pract Otorhinolaryngol
Innervation of human nasal glands
J Neurocytol
Distribution and clinical significance of the autonomic nervous system in the human nasal mucosa
Acta Otolaryngol
Cited by (173)
Airway transcriptome networks identify susceptibility to frequent asthma exacerbations in children
2023, Journal of Allergy and Clinical ImmunologyRegulation of breathing by cardiopulmonary afferents <sup>☆</sup>
2022, Handbook of Clinical NeurologyProtective role of lycopene in experımental allergic rhinitis in rats
2021, International Journal of Pediatric OtorhinolaryngologyEndoscopic vidian and vidian-branch neurectomy for refractory allergic rhinitis: A systematic review
2024, International Forum of Allergy and RhinologyExpression of NMU and NMUR1 in tryptase-positive mast cells and PBLs in allergic rhinitis patients’ nasal mucosa
2024, American Journal of Rhinology and Allergy
(Supported by an unrestricted educational grant from Genentech, Inc. and Novartis Pharmaceuticals Corporation)
Series editors: William T. Shearer, MD, PhD, Lanny J. Rosenwasser, MD, and Bruce S. Bochner, MD
Disclosure of potential conflict of interest: A. Togias has consultant arrangements with AirPharma, Altana, Genentech, GlaxoSmithKline, MedPointe, Merck, and Novartis and is on the speakers' bureau for Genentech, Merck, and Novartis. A. Sanico has consultant arrangements with Merck and AstraZeneca; has received grant support from NIH K23, Merck, and Alcon; and is on the speakers' bureau for Merck, Pfizer, UCB, GlaxoSmithKline, and Aventis. The rest of the authors have declared that they have no conflict of interest.